US 10981860
Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof
granted A61KA61K31/445A61K31/46
Quick answer
US patent 10981860 (Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof) held by Medshine Discovery Inc. expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/445, A61K31/46, A61P, A61P43/00